ATS 2018 International Conference - Mobile

A High Throughput Drug Screen Identifies Glycogen Synthase Kinase (GSK)-3β Inhibition as a Key Regulator of Lymphangiogenesis [Board No. 917]

Location: Board no. 917

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Tuesday

May

22

9:15 AM

11:15 AM

Speaker(s)/Author(s)

Carmen Priolo

MD PhD
Brigham and Women's Hospital

Ivan O. Rosas

MD
Brigham and Women’s Hospital, Harvard Medical School;Brigham and Women's Hospital

Xingbin Ai

Ph.D.
Brigham & Women's Hospital;Brigham and Women's Hospital

Ye Cui

MD, PhD
Brigham and Women's Hospital

Benjamin Stump

MD MPH
Brigham and Women's Hospital

Souheil Y. El-Chemaly

MD, MPH
Brigham and Women's Hospital

Anthony Mark. Lamattina

BS
Brigham and Women's Hospital

Mark A. Perrella

MD
Brigham and Womens Hospital;Brigham and Women's Hospital

View Abstract

A High Throughput Drug Screen Identifies Glycogen Synthase Kinase (GSK)-3β Inhibition as a Key Regulator of Lymphangiogenesis

Parent Sessions

C28 - ROLE OF CELLULAR CROSS TALK IN LUNG HOMEOSTASIS AND AGING...
05-22-2018 9:15 AM - 11:15 AM